Last reviewed · How we verify

Dapsone plus Adapalene

Allergan · FDA-approved active Small molecule

Dapsone reduces inflammation and bacterial growth while adapalene normalizes skin cell turnover and reduces sebum production, together targeting acne pathogenesis.

Dapsone reduces inflammation and bacterial growth while adapalene normalizes skin cell turnover and reduces sebum production, together targeting acne pathogenesis. Used for Acne vulgaris.

At a glance

Generic nameDapsone plus Adapalene
Also known asAczone® Gel 5%, Differin® 0.3% Gel
SponsorAllergan
Drug classRetinoid plus sulfone antibiotic combination
TargetRetinoic acid receptors (adapalene); dihydrofolate reductase inhibition and neutrophil suppression (dapsone)
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Dapsone is a sulfone antibiotic with anti-inflammatory properties that inhibits neutrophil function and has mild antimicrobial activity against Cutibacterium acnes. Adapalene is a third-generation retinoid that binds retinoic acid receptors to normalize keratinization, reduce comedone formation, and decrease sebaceous gland activity. The combination addresses multiple acne pathogenic factors: inflammation, bacterial colonization, and follicular obstruction.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results